Beam
Jimmy Wagstaff is a seasoned professional in the biotechnology sector, currently serving as the Senior Director and Head of Manufacturing at Beam Therapeutics. Previously, Jimmy held the position of Associate Director of Manufacturing at Novartis Gene Therapies, where significant contributions were made to gene therapy initiatives. Additionally, Jimmy's experience includes serving as Senior Manager of Operations for Recovery DAPI US at Novo Nordisk, further emphasizing a strong background in manufacturing and operational excellence in the life sciences industry.
This person is not in any teams
This person is not in any offices
Beam
10 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.